CARTITUDE-1: Phase 1b/2 Study of Ciltacabtagene Autoleucel, a B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy, in Relapsed/Refractory Multiple Myeloma

被引:64
|
作者
Madduri, Deepu
Berdeja, Jesus G.
Usmani, Saad Z.
Jakubowiak, Andrzej
Agha, Mounzer
Cohen, Adam D.
Stewart, A. Keith
Hari, Parameswaran
Htut, Myo
O'Donnell, Elizabeth
Munshi, Nikhil C.
Avigan, David E.
Deol, Abhinav
Lesokhin, Alexander M.
Singh, Indrajeet
Zudaire, Enrique
Yeh, Tzu-Min
Allred, Alicia J.
Olyslager, Yunsi
Banerjee, Arnob
Goldberg, Jenna D.
Schecter, Jordan M.
Jackson, Carolyn C.
Deraedt, William
Zhuang, Sen Hong
Infante, Jeffrey R.
Geng, Dong
Wu, Xiaoling
Carrasco, Marlene J.
Akram, Muhammad
Hossain, Farah
Rizvi, Syed
Fan, Frank
Jagannath, Sundar
Lin, Yi
Martin, Thomas, III
机构
关键词
D O I
10.1182/blood-2020-136307
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:5
相关论文
共 50 条
  • [21] CARTITUDE-2 Cohort B: Efficacy and Safety of Ciltacabtagene Autoleucel, a Chimeric Antigen Receptor T-Cell Therapy Directed Against B-Cell Maturation Antigen, in Patients With Multiple Myeloma and Early Relapse After Initial Treatment
    Van de Donk, Niels W. C. J.
    Delforge, Michel
    Agha, Mounzer
    Cohen, Adam D.
    Cohen, Yael C.
    Hillengass, Jens
    Anguille, Sebastien
    Kerre, Tessa
    Roeloffzen, Wilfried
    Schecter, Jordan M.
    De Braganca, Kevin C.
    Varsos, Helen
    Wang, Liwei
    Vogel, Martin
    Zudaire, Enrique
    Corsale, Christina
    Akram, Muhammad
    Geng, Dong
    Nesheiwat, Tonia
    Pacaud, Lida
    Sonneveld, Pieter
    Zweegman, Sonja
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 : 118 - 119
  • [22] Results from CARTITUDE-1: A Phase 1b/2 Study of JNJ-4528, a CAR-T Cell Therapy Directed Against B-Cell Maturation Antigen (BCMA), in Patients with Relapsed and/or Refractory Multiple Myeloma (R/R MM)
    Madduri, Deepu
    Usmani, Saad Z.
    Jagannath, Sundar
    Singh, Indrajeet
    Zudaire, Enrique
    Yeh, Tzu-Min
    Allred, Alicia J.
    Banerjee, Arnob
    Goldberg, Jenna D.
    Schecter, Jordan M.
    Zhuang, Sen
    Infante, Jeffrey R.
    Rizvi, Syed
    Fan, Xiaohu
    Jakubowiak, Andrzej
    Berdeja, Jesus G.
    BLOOD, 2019, 134
  • [23] Update of CARTITUDE-1: A phase Ib/II study of JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell therapy, in relapsed/refractory multiple myeloma.
    Berdeja, Jesus G.
    Madduri, Deepu
    Usmani, Saad Zafar
    Singh, Indrajeet
    Zudaire, Enrique
    Yeh, Tzu-Min
    Allred, Alicia J.
    Olyslager, Yunsi
    Banerjee, Arnob
    Goldberg, Jenna D.
    Schecter, Jordan
    Geng, Dong
    Wu, Xiaoling
    Carrasco-Alfonso, Marlene
    Rizvi, Syed
    Fan, Frank
    Jakubowiak, Andrzej J.
    Jagannath, Sundar
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [24] Phase II, Open-Label Study of Ciltacabtagene Autoleucel, an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor-T-Cell Therapy, in Chinese Patients With Relapsed/Refractory Multiple Myeloma (CARTIFAN-1)
    Mi, Jian-Qing
    Zhao, Wanhong
    Jing, Hongmei
    Fu, Weijun
    Hu, Jianda
    Chen, Lijuan
    Zhang, Yiwen
    Yao, Dan
    Chen, Diana
    Schecter, Jordan M.
    Yang, Fan
    Tian, Xiaochen
    Sun, Huabin
    Zhuang, Sen Hong
    Ren, Jimmy
    Fan, Xiaohu
    Jin, Jie
    Niu, Ting
    Chen, Sai-Juan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (06) : 1275 - +
  • [25] Ciltacabtagene autoleucel CAR-T therapy targeting B-cell maturation antigen (BCMA) Treatment of multiple myeloma
    Lee, Sarah
    Cowan, Andrew J.
    DRUGS OF THE FUTURE, 2022, 47 (04) : 233 - 238
  • [26] A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma
    Zhao, Wan-Hong
    Liu, Jie
    Wang, Bai-Yan
    Chen, Yin-Xia
    Cao, Xing-Mei
    Yang, Yun
    Zhang, Yi-Lin
    Wang, Fang-Xia
    Zhang, Peng-Yu
    Lei, Bo
    Gu, Liu-Fang
    Wang, Jian-Li
    Yang, Nan
    Zhang, Ru
    Zhang, Hui
    Shen, Ying
    Xu, Ju Bai Yan
    Wang, Xu-Geng
    Zhang, Rui-Li
    Wei, Li-Li
    Li, Zong-Fang
    Li, Zhen-Zhen
    Geng, Yan
    He, Qian
    Zhuang, Qiu-Chuan
    Fan, Xiao-Hu
    He, Ai-Li
    Zhang, Wang-Gang
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [27] Early Time-to-Tocilizumab after B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy in Myeloma
    Banerjee, Rahul
    Marsal, Jeffrey
    Huang, Chiung-Yu
    Lo, Mimi
    Kambhampati, Swetha
    Kennedy, Vanessa E.
    Arora, Shagun
    Wolf, Jeffrey L.
    Martin, Thomas G.
    Wong, Sandy W.
    Shah, Nina
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (06): : 477.e1 - 477.e7
  • [28] A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma
    Wan-Hong Zhao
    Jie Liu
    Bai-Yan Wang
    Yin-Xia Chen
    Xing-Mei Cao
    Yun Yang
    Yi-Lin Zhang
    Fang-Xia Wang
    Peng-Yu Zhang
    Bo Lei
    Liu-Fang Gu
    Jian-Li Wang
    Nan Yang
    Ru Zhang
    Hui Zhang
    Ying Shen
    Ju Bai
    Yan Xu
    Xu-Geng Wang
    Rui-Li Zhang
    Li-Li Wei
    Zong-Fang Li
    Zhen-Zhen Li
    Yan Geng
    Qian He
    Qiu-Chuan Zhuang
    Xiao-Hu Fan
    Ai-Li He
    Wang-Gang Zhang
    Journal of Hematology & Oncology, 11
  • [29] Health-Related Quality of Life in the Cartitude-1 Study of Ciltacabtagene Autoleucel for Relapsed/Refractory Multiple Myeloma
    Martin, Thomas, III
    Lin, Yi
    Agha, Mounzer
    Cohen, Adam D.
    Htut, Myo
    Stewart, A. Keith
    Hari, Parameswaran
    Berdeja, Jesus G.
    Madduri, Deepu
    Usmani, Saad Z.
    Yeh, Tzu-Min
    Allred, Alicia J.
    Olyslager, Yunsi
    Banerjee, Arnob
    Goldberg, Jenna D.
    Schecter, Jordan M.
    Jackson, Carolyn C.
    Deraedt, William
    Gries, Katharine S.
    Fastenau, John
    Wu, Xiaoling
    Carrasco, Marlene J.
    Akram, Muhammad
    Hossain, Farah
    Jakubowiak, Andrzej
    Jagannath, Sundar
    BLOOD, 2020, 136
  • [30] Plain language summary of the CARTITUDE-1 study of ciltacabtagene autoleucel for the treatment of people with relapsed or refractory multiple myeloma
    Berdeja, Jesus G.
    Cohen, Adam D.
    Martin, Thomas
    Madduri, Deepu
    Pacaud, Lida
    Jagannath, Sundar
    FUTURE ONCOLOGY, 2023, 19 (18) : 1235 - 1247